CSI Market
Sign In | Register

An2 Therapeutics Inc (ANTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access ANTX quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in An2 Therapeutics Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ANTX/balance-sheets
https://api.csimarket.com/api/v1/companies/ANTX/fundamentals
https://api.csimarket.com/api/v1/companies/ANTX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent19.94
Available-for-sale Securities, Debt Securities, Current MA38.06
Cash & Short-term Investments57.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.94
Total Current Assets59.94
Long-term investments2.01
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent2.01
Operating Lease Right Of Use Asset Current-
Total Assets61.95
Liabilities
Accounts Payable, Current AC3.02
Accrued Liabilities, Current4.47
Other Liabilities, Current1.23
Taxes Payable0.00
Total Current Liabilities8.72
Total Long-term Debt0.00
Other liabilities, Noncurrent0.17
OptionsSubjectToRepurchaseLongTerm-
Operating Lease Liability Current-
Options Subject To Repurchase Short Term-
Total Liabilities8.89
Stockholders' Equity
Additional Paid In Capital Common Stock293.95
Retained Earnings / Accumulated Deficit-240.95
Accumulated Other Comprehensive Income0.00
Other Equity0.06
Common Stockholder's Equity53.06
Total Stockholder's Equity53.06
Liabilities & Stockholder's Equity61.95
4 historic quarters locked

Sign in to unlock the full An2 Therapeutics Inc balance sheet history.

Sign In Create Free Account

About An2 Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-110693

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI